viernes, 7 de diciembre de 2018

In CAR-T, manufacturing a hurdle Novartis has yet to clear | BioPharma Dive

In CAR-T, manufacturing a hurdle Novartis has yet to clear | BioPharma Dive

The Readout

Damian Garde

In CAR-T, manufacturing a hurdle Novartis has yet to clear

No hay comentarios: